3448 results for «2025年159569分红记录»
3448 results
What did we learn from my TAVI complications?
22 May 2025 – From EuroPCR 2025
Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.
Pharmacotherapy coronary interventions: new insights
22 May 2025 – From EuroPCR 2025
Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...
Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
Challenges and risks of percutaneous treatment of calcified lesions
22 May 2025 – From EuroPCR 2025
Learn how to effectively manage calcified coronary lesions and their associated risks in this focused session. Understand the critical role of plaque modification and intravascular imaging, and gain insights into addressing stent thrombosis following interventions on calcified lesions through detailed case analyses.
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Acute complications during distal left main PCI - Part 1
22 May 2025 – From EuroPCR 2025
Navigate the challenges of acute complications during distal left main PCI with expert guidance. This session discusses troubleshooting techniques for stuck IVUS catheters, stepwise ostial LAD stenting, OCT applications when crush and kiss techniques fail, management of lost stents in heavily calcified bifurcations, and responses to...
Optimised patient selection for carotid artery stenting
22 May 2025 – From EuroPCR 2025
Optimize patient selection for carotid artery stenting with this session that highlights personalized approaches to ischaemic stroke treatment. Review bioactive stents versus endovascular therapy, feasibility and outcomes in near-occlusion cases, and long-term retrospective analyses supporting carotid stenting as a strategic ally in embolic stroke management.
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Coronary complications: perforation and dissection
22 May 2025 – From EuroPCR 2025
Examine the unpredictable nature of coronary complications such as perforation and dissection during PCI. This session presents real-world cases illustrating sequential complications, their management challenges, and strategies to simplify complex scenarios. Understand how to anticipate, recognize, and effectively respond to these critical incidents to improve procedural...
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
How to treat - DCB
21 May 2025 – From EuroPCR 2025
Explore drug-coated balloon (DCB) therapy through detailed case studies covering calcified vessels, small diffuse vessel disease, and de novo ostial lesions. Gain practical insights on treatment approaches and key learning points to enhance your DCB practice.
Improving outcomes of NSTEMI patients
21 May 2025 – From EuroPCR 2025
Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously
21 May 2025 – From EuroPCR 2025
This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.
Two-stent techniques for non-left main true bifurcation lesions
22 May 2025 – From EuroPCR 2025
Enhance your skills in two-stent techniques for non-left main true bifurcation lesions. This session covers patient and lesion assessment, PCI procedural steps, and common pitfalls to avoid, aiming to improve procedural success in complex coronary anatomies.
Challenging clinical scenarios in coronary artery disease
21 May 2025 – From EuroPCR 2025
Confront challenging clinical scenarios in coronary artery disease with case-based discussions. Topics include managing multiple stent layers, late mediastinal hematoma, PCI optimization through physiology and imaging, refractory angina treatment, and acute tamponade management.
Therapeutic choices for TTVIV-TTVIR interventions
21 May 2025 – From EuroPCR 2025
Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
Mitral TEER in challenging scenarios - Part 3
21 May 2025 – From EuroPCR 2025
This session focuses on challenging mitral TEER cases, including papillary muscle rupture post-myocardial infarction, advanced heart failure treatment, emerging therapies for mitral regurgitation, and novel percutaneous repair techniques.
